{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T11:17:22Z","timestamp":1780658242714,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32CA009621"],"award-info":[{"award-number":["T32CA009621"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1245\/s10434-025-17939-w","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T16:04:20Z","timestamp":1753200260000},"page":"8485-8491","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Are Broadened Guidelines Improving our Detection of Pathologic Genetic Mutations in Breast Cancer Patients? A 5-Year Comparative Analysis of American Society of Breast Surgeons and National Comprehensive Cancer Network Guidelines"],"prefix":"10.1245","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9805-2789","authenticated-orcid":false,"given":"Ariana","family":"Naaseh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia X.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda R.","family":"Maytin-Hevia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Margenthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"issue":"4","key":"17939_CR1","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.amjsurg.2016.06.010","volume":"212","author":"KK Ludwig","year":"2016","unstructured":"Ludwig KK, Neuner J, Butler A, Geurts JL, Kong AL. Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review. Am J Surg. 2016;212(4):660\u20139. https:\/\/doi.org\/10.1016\/j.amjsurg.2016.06.010.","journal-title":"Am J Surg."},{"issue":"5","key":"17939_CR2","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJMra1503523","volume":"374","author":"LC Hartmann","year":"2016","unstructured":"Hartmann LC, Lindor NM. The role of risk-reducing surgery in hereditary breast and ovarian cancer. N Engl J Med. 2016;374(5):454\u201368. https:\/\/doi.org\/10.1056\/NEJMra1503523.","journal-title":"N Engl J Med."},{"issue":"11","key":"17939_CR3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3390\/cancers10110424","volume":"10","author":"R Manchanda","year":"2018","unstructured":"Manchanda R, Gaba F. Population based testing for primary prevention: a systematic review. Cancers. 2018;10(11):424. https:\/\/doi.org\/10.3390\/cancers10110424.","journal-title":"Cancers."},{"issue":"1","key":"17939_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41523-022-00411-3","volume":"8","author":"N Tung","year":"2022","unstructured":"Tung N, Garber JE. PARP inhibition in breast cancer: progress made and future hopes. NPJ Breast Cancer. 2022;8(1):1\u20135. https:\/\/doi.org\/10.1038\/s41523-022-00411-3.","journal-title":"NPJ Breast Cancer."},{"key":"17939_CR5","doi-asserted-by":"publisher","unstructured":"Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N Engl J Med. 2025. https:\/\/doi.org\/10.1056\/NEJMoa1706450.","DOI":"10.1056\/NEJMoa1706450"},{"key":"17939_CR6","unstructured":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews - PubMed. Accessed April 24, 2025. https:\/\/pubmed.ncbi.nlm.nih.gov\/9145676\/."},{"issue":"1","key":"17939_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cncr.29010","volume":"121","author":"N Tung","year":"2015","unstructured":"Tung N, Battelli C, Allen B, et al. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Cancer. 2015;121(1):25\u201333. https:\/\/doi.org\/10.1002\/cncr.29010.","journal-title":"Cancer."},{"issue":"1","key":"17939_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","volume":"19","author":"MB Daly","year":"2021","unstructured":"Daly MB, Pal T, Berry MP, et al. Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw JNCCN. 2021;19(1):77\u2013102. https:\/\/doi.org\/10.6004\/jnccn.2021.0001.","journal-title":"J Natl Compr Cancer Netw JNCCN."},{"issue":"5","key":"17939_CR9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.4428","volume":"2","author":"Z Kemp","year":"2019","unstructured":"Kemp Z, Turnbull A, Yost S, et al. Evaluation of cancer-based criteria for use in mainstream BRCA1 and BRCA2 genetic testing in patients with breast cancer. JAMA Netw Open. 2019;2(5):e194428. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.4428.","journal-title":"JAMA Netw Open."},{"issue":"6","key":"17939_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/JCO.18.01631","volume":"37","author":"PD Beitsch","year":"2019","unstructured":"Beitsch PD, Whitworth PW, Hughes K, et al. Underdiagnosis of hereditary breast cancer: are genetic testing guidelines a tool or an obstacle? J Clin Oncol. 2019;37(6):453\u201360. https:\/\/doi.org\/10.1200\/JCO.18.01631.","journal-title":"J Clin Oncol."},{"issue":"4","key":"17939_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/GIM.0b013e3182091ba4","volume":"13","author":"DE Levy","year":"2011","unstructured":"Levy DE, Byfield SD, Comstock CB, et al. Underutilization of BRCA1\/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. Genet Med. 2011;13(4):349\u201355. https:\/\/doi.org\/10.1097\/GIM.0b013e3182091ba4.","journal-title":"Genet Med."},{"issue":"10","key":"17939_CR12","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1245\/s10434-019-07549-8","volume":"26","author":"ER Manahan","year":"2019","unstructured":"Manahan ER, Kuerer HM, Sebastian M, et al. Consensus guidelines on genetic testing for hereditary breast cancer from the American society of breast surgeons. Ann Surg Oncol. 2019;26(10):3025\u201331. https:\/\/doi.org\/10.1245\/s10434-019-07549-8.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"17939_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.31427","volume":"7","author":"Z Rezoug","year":"2024","unstructured":"Rezoug Z, Totten SP, Szlachtycz D, et al. Universal genetic testing for newly diagnosed invasive breast cancer. JAMA Netw Open. 2024;7(9):e2431427. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.31427.","journal-title":"JAMA Netw Open."},{"issue":"12","key":"17939_CR14","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1001\/jamaoncol.2019.3323","volume":"5","author":"L Sun","year":"2019","unstructured":"Sun L, Brentnall A, Patel S, et al. A cost-effectiveness analysis of multigene testing for all patients with breast cancer. JAMA Oncol. 2019;5(12):1718\u201330. https:\/\/doi.org\/10.1001\/jamaoncol.2019.3323.","journal-title":"JAMA Oncol."},{"issue":"15","key":"17939_CR15","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1016\/s0959-8049(02)00264-2","volume":"38","author":"B Meiser","year":"2002","unstructured":"Meiser B, Butow P, Friedlander M, et al. Psychological impact of genetic testing in women from high-risk breast cancer families. Eur J Cancer Oxf Engl 1990. 2002;38(15):2025\u201331. https:\/\/doi.org\/10.1016\/s0959-8049(02)00264-2.","journal-title":"Eur J Cancer Oxf Engl 1990"},{"issue":"2","key":"17939_CR16","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1001\/jamaoncol.2020.6252","volume":"7","author":"NJ Samadder","year":"2021","unstructured":"Samadder NJ, Riegert-Johnson D, Boardman L, et al. Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome. JAMA Oncol. 2021;7(2):230\u20137. https:\/\/doi.org\/10.1001\/jamaoncol.2020.6252.","journal-title":"JAMA Oncol."},{"issue":"12","key":"17939_CR17","doi-asserted-by":"publisher","first-page":"13019","DOI":"10.1002\/cam4.5976","volume":"12","author":"M Ni","year":"2023","unstructured":"Ni M, Wang F, Yang A, et al. What is the appropriate genetic testing criteria for breast cancer in the Chinese population?\u2014Analysis of genetic and clinical features from a single cancer center database. Cancer Med. 2023;12(12):13019\u201330. https:\/\/doi.org\/10.1002\/cam4.5976.","journal-title":"Cancer Med."},{"issue":"1","key":"17939_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1245\/s10434-023-14394-3","volume":"31","author":"C Shelton","year":"2024","unstructured":"Shelton C, Ruiz A, Shelton L, et al. Universal germline-genetic testing for breast cancer: implementation in a rural practice and impact on shared decision-making. Ann Surg Oncol. 2024;31(1):325\u201334. https:\/\/doi.org\/10.1245\/s10434-023-14394-3.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"17939_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform."},{"key":"17939_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208. https:\/\/doi.org\/10.1016\/j.jbi.2019.103208.","journal-title":"J Biomed Inform."},{"issue":"4","key":"17939_CR21","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37428","volume":"15","author":"JC Jones","year":"2023","unstructured":"Jones JC, Golafshar MA, Coston TW, et al. Universal genetic testing vs guideline-directed testing for hereditary cancer syndromes among traditionally underrepresented patients in a community oncology program. Cureus. 2023;15(4):e37428. https:\/\/doi.org\/10.7759\/cureus.37428.","journal-title":"Cureus."},{"issue":"13","key":"17939_CR22","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1002\/cncr.30621","volume":"123","author":"D Cragun","year":"2017","unstructured":"Cragun D, Weidner A, Lewis C, et al. Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors. Cancer. 2017;123(13):2497\u2013505. https:\/\/doi.org\/10.1002\/cncr.30621.","journal-title":"Cancer."},{"issue":"11","key":"17939_CR23","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1136\/jmg.2007.051268","volume":"44","author":"S Masciari","year":"2007","unstructured":"Masciari S, Larsson N, Senz J, et al. Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet. 2007;44(11):726\u201331. https:\/\/doi.org\/10.1136\/jmg.2007.051268.","journal-title":"J Med Genet."},{"issue":"1","key":"17939_CR24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/1055-9965.EPI-11-0775","volume":"21","author":"N Mavaddat","year":"2012","unstructured":"Mavaddat N, Barrowdale D, Andrulis IL, et al. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the consortium of investigators of modifiers of BRCA1\/2 (CIMBA). Cancer Epidemiol Biomarkers Prev. 2012;21(1):134\u201347. https:\/\/doi.org\/10.1158\/1055-9965.EPI-11-0775.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"4","key":"17939_CR25","doi-asserted-by":"publisher","first-page":"djv362","DOI":"10.1093\/jnci\/djv362","volume":"108","author":"C Le Tourneau","year":"2016","unstructured":"Le Tourneau C, Kamal M, Tsimberidou AM, et al. Treatment algorithms based on tumor molecular profiling: the essence of precision medicine trials. JNCI J Natl Cancer Inst. 2016;108(4):djv362. https:\/\/doi.org\/10.1093\/jnci\/djv362.","journal-title":"JNCI J Natl Cancer Inst."},{"issue":"13","key":"17939_CR26","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1245\/s10434-014-3711-9","volume":"21","author":"PD Beitsch","year":"2014","unstructured":"Beitsch PD, Whitworth PW. Can breast surgeons provide breast cancer genetic testing? An American society of breast surgeons survey. Ann Surg Oncol. 2014;21(13):4104\u20138. https:\/\/doi.org\/10.1245\/s10434-014-3711-9.","journal-title":"Ann Surg Oncol."},{"issue":"36","key":"17939_CR27","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.1200\/JCO.20.02151","volume":"38","author":"NM Tung","year":"2020","unstructured":"Tung NM, Robson ME, Ventz S, et al. TBCRC 048: phase II study of olaparib for metastatic breast cancer and mutations in homologous recombination-related genes. J Clin Oncol. 2020;38(36):4274\u201382. https:\/\/doi.org\/10.1200\/JCO.20.02151.","journal-title":"J Clin Oncol."},{"issue":"9","key":"17939_CR28","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jama.2010.1237","volume":"304","author":"SM Domchek","year":"2010","unstructured":"Domchek SM, Friebel TM, Singer CF, et al. association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010;304(9):967\u201375. https:\/\/doi.org\/10.1001\/jama.2010.1237.","journal-title":"JAMA."},{"issue":"12","key":"17939_CR29","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1001\/archsurg.138.12.1323","volume":"138","author":"JN Weitzel","year":"2003","unstructured":"Weitzel JN, McCaffrey SM, Nedelcu R, MacDonald DJ, Blazer KR, Cullinane CA. Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Arch Surg. 2003;138(12):1323\u20138. https:\/\/doi.org\/10.1001\/archsurg.138.12.1323.","journal-title":"Arch Surg."},{"issue":"3","key":"17939_CR30","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/jgc4.1078","volume":"28","author":"JR Canedo","year":"2019","unstructured":"Canedo JR, Miller ST, Myers HF, Sanderson M. Racial and ethnic differences in knowledge and attitudes about genetic testing in the U.S.: systematic review. J Genet Couns. 2019;28(3):587\u2013601. https:\/\/doi.org\/10.1002\/jgc4.1078.","journal-title":"J Genet Couns."},{"issue":"3","key":"17939_CR31","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s40615-018-00556-7","volume":"6","author":"CD Williams","year":"2019","unstructured":"Williams CD, Bullard AJ, O\u2019Leary M, Thomas R, Redding TS, Goldstein K. Racial\/ethnic disparities in BRCA counseling and testing: a narrative review. J Racial Ethn Health Disparities. 2019;6(3):570\u201383. https:\/\/doi.org\/10.1007\/s40615-018-00556-7.","journal-title":"J Racial Ethn Health Disparities."},{"issue":"15","key":"17939_CR32","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1200\/JCO.18.01854","volume":"37","author":"AW Kurian","year":"2019","unstructured":"Kurian AW, Ward KC, Howlader N, et al. Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients. J Clin Oncol. 2019;37(15):1305\u201315. https:\/\/doi.org\/10.1200\/JCO.18.01854.","journal-title":"J Clin Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17939-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17939-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17939-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:06:46Z","timestamp":1759507606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17939-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["17939"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17939-w","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"16 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have no disclosures or conflicts of interest related to this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}